These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28782088)

  • 1. Reconstitution of a ligand-binding competent murine NKp30 receptor.
    Memmer S; Weil S; Koch J
    Immunogenetics; 2018 Mar; 70(3):185-194. PubMed ID: 28782088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli.
    Hollyoake M; Campbell RD; Aguado B
    Mol Biol Evol; 2005 Aug; 22(8):1661-72. PubMed ID: 15872155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding.
    Hartmann J; Tran TV; Kaudeer J; Oberle K; Herrmann J; Quagliano I; Abel T; Cohnen A; Gatterdam V; Jacobs A; Wollscheid B; Tampé R; Watzl C; Diefenbach A; Koch J
    J Biol Chem; 2012 Sep; 287(37):31527-39. PubMed ID: 22807449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines.
    Bjørnsen EG; Thiruchelvam-Kyle L; Hoelsbrekken SE; Henden C; Saether PC; Boysen P; Daws MR; Dissen E
    Eur J Immunol; 2019 Jan; 49(1):54-65. PubMed ID: 30512185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells.
    Binici J; Hartmann J; Herrmann J; Schreiber C; Beyer S; Güler G; Vogel V; Tumulka F; Abele R; Mäntele W; Koch J
    J Biol Chem; 2013 Nov; 288(48):34295-303. PubMed ID: 24133212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and functional identification of a monoclonal antibody against the recombinant soluble human NKp30 receptor.
    Wang H; Zheng X; Wei H; Tian Z; Sun R
    Int Immunopharmacol; 2011 Nov; 11(11):1732-9. PubMed ID: 21718806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.
    Herrmann J; Berberich H; Hartmann J; Beyer S; Davies K; Koch J
    J Biol Chem; 2014 Jan; 289(2):765-77. PubMed ID: 24275655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack.
    Wang W; Guo H; Geng J; Zheng X; Wei H; Sun R; Tian Z
    J Biol Chem; 2014 Nov; 289(48):33311-9. PubMed ID: 25315772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
    Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.
    Hecht ML; Rosental B; Horlacher T; Hershkovitz O; De Paz JL; Noti C; Schauer S; Porgador A; Seeberger PH
    J Proteome Res; 2009 Feb; 8(2):712-20. PubMed ID: 19196184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex.
    Memmer S; Weil S; Beyer S; Zöller T; Peters E; Hartmann J; Steinle A; Koch J
    J Biol Chem; 2016 Dec; 291(49):25427-25438. PubMed ID: 27754869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
    Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M
    J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.
    Koch J; Steinle A; Watzl C; Mandelboim O
    Trends Immunol; 2013 Apr; 34(4):182-91. PubMed ID: 23414611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coevolution of MHC genes (LMP/TAP/class Ia, NKT-class Ib, NKp30-B7H6): lessons from cold-blooded vertebrates.
    Ohta Y; Flajnik MF
    Immunol Rev; 2015 Sep; 267(1):6-15. PubMed ID: 26284468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules.
    Tallerico R; Todaro M; Di Franco S; Maccalli C; Garofalo C; Sottile R; Palmieri C; Tirinato L; Pangigadde PN; La Rocca R; Mandelboim O; Stassi G; Di Fabrizio E; Parmiani G; Moretta A; Dieli F; Kärre K; Carbone E
    J Immunol; 2013 Mar; 190(5):2381-90. PubMed ID: 23345327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.
    Hershkovitz O; Jarahian M; Zilka A; Bar-Ilan A; Landau G; Jivov S; Tekoah Y; Glicklis R; Gallagher JT; Hoffmann SC; Zer H; Mandelboim O; Watzl C; Momburg F; Porgador A
    Glycobiology; 2008 Jan; 18(1):28-41. PubMed ID: 18006589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan.
    Warren HS; Jones AL; Freeman C; Bettadapura J; Parish CR
    J Immunol; 2005 Jul; 175(1):207-12. PubMed ID: 15972650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
    Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma.
    Mantovani S; Oliviero B; Lombardi A; Varchetta S; Mele D; Sangiovanni A; Rossi G; Donadon M; Torzilli G; Soldani C; Porta C; Pedrazzoli P; Chiellino S; Santambrogio R; Opocher E; Maestri M; Bernuzzi S; Rossello A; Clément S; De Vito C; Rubbia-Brandt L; Negro F; Mondelli MU
    Hepatology; 2019 Mar; 69(3):1165-1179. PubMed ID: 30153337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
    Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
    Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.